Concurrence of Myelodysplastic syndromes and large granular lymphocyte leukemia: clinicopathological features, mutational profile and gene ontology analysis in a single center.
Lists
Only you see this
Abstract
The concurrence of Myelodysplastic syndromes (MDS) and large granular lymphocyte leukemia (LGLL) has been reported in a small group of patients and might suggest an etiologic relationship rather than a simple coincidence. In this present study, clinicopathological features were detailed in ten cases of MDS concurrent with LGLL (MDS-LGLL). These cases included seven patients with T-LGLL, two with mixed-phenotype LGLL, and one with CLPD-NK. Subsequently, gene mutation screening for commonly myeloid-related or lymphoid-related genes was performed in MDS-LGLL patients by using next generation sequencing (NGS). The genes with the highest frequency of mutations were <i>ASXL1</i> (3/10, 30%) and <i>STAG2</i> (3/10, 30%) among a panel of 114 genes. LGLL-associated mutations of <i>STAT3</i> (2/10, 20%) and <i>STAT5b</i> (1/10, 10%) were also detected. Moreover, whole-exome sequencing (WES) and gene ontology (GO) analysis for one patient in his different phases revealed increased enrichment of histone H3 lysine 4 (H3K4) mono-methylation (GO:0097692) pathway and decreased enrichment of translocation of ZAP-70 to immunological synapse (R-HAS-202430) pathway upon progression from MDS to MDS-LGLL.
BibTeX
@inproceedings{ai2021concurrence,
author = {Kexin Ai and Minming Li and Ping Wu and Chengxin Deng and Xin Huang and Ling Wei and Ruohao Xu and Suxia Geng and Qihui Sun and Jianyu Weng and Xin Du},
title = {{Concurrence of Myelodysplastic syndromes and large granular lymphocyte leukemia: clinicopathological features, mutational profile and gene ontology analysis in a single center.}},
booktitle = {PubMed},
year = {2021},
}Loading related content...